ERBB2 and breast cancer: SOLTI-1905 ELIPSE was a phase I study investigating the effect of preoperative elacestrant monotherapy on cancer cell proliferation in postmenopausal women with treatment-naïve ER+ HER2− early stage breast cancer [32].